Broadline
eprinomectin, fipronil, praziquantel, (S)-methoprene
Table of contents
Overview
Broadline is a veterinary medicine used to treat cats with, or at risk of, mixed infestations by tapeworms, roundworms and external parasites (fleas, ticks, and a burrowing mite called Notoedres cati which is a cause of mange). The product is to be used only when all three groups of parasites are targeted at the same time.
For external parasites, Broadline treats flea infestations and prevents new infestations for at least one month; it also prevents environmental flea contamination for over a month. It may also be used as part of a treatment strategy for flea allergy dermatitis (an allergic reaction to flea bites). It treats tick infestations and prevents new infestations for up to three weeks.
For worms, Broadline is used to treat tapeworms, roundworms and hookworms in the gut as well as a type of worm that infects the bladder and two types of feline lungworm. Broadline can also be used to prevent heartworm disease for one month.
Broadline contains four active substances: fipronil, (S)-methoprene, eprinomectin and praziquantel.
Authorisation details
Product details | |
---|---|
Name |
Broadline
|
Agency product number |
EMEA/V/C/002700
|
Active substance |
|
International non-proprietary name (INN) or common name |
eprinomectin, fipronil, praziquantel, (S)-methoprene
|
Species |
Cats
|
Anatomical therapeutic chemical veterinary (ATCvet) codes |
QP54AA54
|
Publication details | |
---|---|
Marketing-authorisation holder |
Boehringer Ingelheim Vetmedica GmbH
|
Revision |
10
|
Date of issue of marketing authorisation valid throughout the European Union |
04/12/2013
|
Contact address |
Binger Strasse 173 |
Product information
20/03/2020 Broadline - EMEA/V/C/002700 - IG/1203
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
-
Antiparasitic products, insecticides and repellents
-
Avermectins
-
Eprinomectin, combinations
Therapeutic indication
For cats with, or at risk from mixed infestations by cestodes, nematodes and ectoparasites. The veterinary medicinal product is exclusively indicated when all three groups are targeted at the same time.
Ectoparasites
- Treatment and prevention of infestations by fleas (Ctenocephalides felis). Elimination of fleas within 24 hours. One treatment prevents further infestations for at least one month.
- Prevention of environmental flea contamination by inhibiting the development of flea immature stages (eggs, larvae and pupae) for over a month.
- The product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).
- Treatment and prevention of infestations by ticks (Ixodes ricinus). Elimination of ticks within 48 hours. One treatment prevents further infestations for up to 3 weeks.
- Treatment of notoedric mange (Notoedres cati).
Cestodes
- Treatment of infestations with tapeworms (Dipylidium caninum, Taenia taeniaeformis, Echinococcus multilocularis, Joyeuxiella pasqualei (adult), and Joyeuxiella fuhrmanni (adult)).
Nematodes
- Treatment of infestations with gastrointestinal nematodes (L3, L4 larvae and adults of Toxocara cati, adults of Toxascaris leonina, L4 larvae and adults of Ancylostoma tubaeforme and Ancylostoma ceylanicum, and adults of Ancylostoma brazilienze).
- Treatment of infestations with feline lungworms (L3 larvae, L4 larvae and adults of Aelurostrongylus abstrusus, L4 larvae and adults of Troglostrongylus brevior).
- Treatment of infestations with vesical worms (Capillaria plica).
- Prevention of heartworm disease (Dirofilaria immitis larvae) for one month.